Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab effects on respiratory microbiome in severe asthma
NCT05036733Phase 4Completed
- Sponsor
- University of Michigan
- Start
- Feb 2022
- Primary completion
- Jun 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of dupilumab in severe asthma, sponsored by University of Michigan. Started Feb 2022; status: completed.
02
Drugs
03
Conditions
severe asthma
Beyond the preview
Go deeper on NCT05036733.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05036733.